Blocking the binding of PD-1 expressed in tumor-infiltrating T lymphocytes to PD-L1 expressed in tumor cells can partially reverse T cell dysfunction and inhibit tumor growth (8–10). The gene discussed is PDCD1; the disease is neoplasm.